Medical Advisor – Rare Diseases – Lithuania (Hybrid Office/Field)

Medical Advisor – Rare Diseases – Lithuania (Hybrid Office/Field) Diverse Minds. Bold Disruptors. Meaningful Impact. AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world’s most serious disease. But we’re more than one of the world’s leading pharmaceutical companies. It’s our patients that come first, every decision we make and action we take is centered around how we can better respond to their evolving needs, as well as those of healthcare professionals and partners. It’s why we are shaping patient care for the future, working along the whole experience to give hope to billions of lives across the world. Key responsibilities As a Medical Advisor, you will combine in-depth scientific expertise with strong external engagement to drive pre-launch excellence, practice change initiatives, and patient pathway optimisation. This hybrid role blends office-based strategy (typically 70%) with in-field activities (typically 30%) across Key External Experts (KEEs), healthcare organisations, and patient advocacy groups. While focused locally, you may be assigned additional Baltic-level responsibilities aligned to our portfolio priorities. What you’ll do · Lead scientific engagement and thought leadership: Conduct evidence-based, non-promotional scientific exchange; speak at scientific meetings per local regulations; organise and chair advisory boards; and co-create transform-care partnerships to enable guideline-directed medical therapy. · Translate insights into strategy: Systematically gather disease-area and clinical practice insights, assess evidence gaps, and shape medical strategies, access plans, and real-world evidence (RWE) priorities in collaboration with cross-functional teams. · Build strategic partnerships: Identify and develop relationships with KEEs, HCOs, PAGs, and other stakeholders to drive collaboration and practice change aligned to launch plans and within budget. · Support evidence generation: Partner with Baltic/CEENA/EUCAN Evidence teams on externally sponsored research, RWE, and prioritized clinical trials (as appropriate), facilitating recruitment awareness and scientific understanding within guidance. · Be the internal scientific expert: Serve on cross-functional value/brand teams; own KEE and congress plans; provide internal training; contribute to reimbursement dossiers and patient access; and perform medical review of promotional and non-promotional materials and relevant regulatory documents. · Own planning and governance: Plan and execute TA medical strategy, including budget planning and tracking, MI responsibilities within the TA, and compliant execution per Baltic SOPs, Global Standards, and Codes of Ethics. · Invest in your development: Continuously advance your disease-area expertise, communication and negotiation capabilities, evidence generation literacy (incl. RWD/RWE), and cross-functional ways of working. · Continuously advance your disease-area expertise, communication and negotiation capabilities, evidence generation literacy (incl. RWD/RWE), and cross-functional ways of working. What you’ll bring · Master’s degree in life sciences or related discipline · Customer-centric mindset with proven ability to collaborate with HCPs/HCOs/PAGs · Strong cross-functional and matrix working skills · Ability to discuss scientific content and present to diverse audiences · Excellent oral and written communication; fluent English · Understanding of the pharmaceutical industry and local healthcare system · Learning agility; strong planning and organisational skills · Ability to travel; valid driver’s license Why AstraZeneca? At AstraZeneca we’re dedicated to being a phe